Kathelijne Peerlinck
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 16, 2024
Emicizumab for acquired haemophilia A: A case series.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: March 07, 2023
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
Journal: The New England journal of medicine
Published: February 22, 2023
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 13, 2022
Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 23, 2022
Ribosome dysfunction underlies SLFN14-related thrombocytopenia.
Journal: Blood
Published: July 08, 2022
Methylome analysis for haemophilia A intron 22 inversion patients with and without inhibitors: A pilot study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 14, 2022
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
Journal: The New England journal of medicine
Published: March 16, 2022
F11 Gene Duplication Causes Elevated FXI Plasma Levels and Is a Risk for Venous Thrombosis.
Journal: Thrombosis and haemostasis
Published: November 15, 2021
Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosing.
Journal: Research and practice in thrombosis and haemostasis
Published: August 06, 2021
Last Updated: 09/26/2026